Manufacturing timeline had already slipped by one quarter...

  1. 300 Posts.
    lightbulb Created with Sketch. 10
    Manufacturing timeline had already slipped by one quarter according to the May 2017 investor presentation compared to earlier in the year. This announcement confirms further slippage. With the tox studies taking 9 months, its hard to see the clinical studies studies starting before middle of 2018. You could argue that this would still bring the study in before the end of 2018 with a 6 month timeline but that would be one of the fastest Phase 1 clinical studies ever. Outcome more like well into 2019 IMO. There is also no detail on what the Phase 1 study looks like, given that they are banking on doing a deal at the outcome of the study.
    I'm with you AC, seems to me plenty of risk taking an entry at this stage.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.3¢
Change
0.001(25.0%)
Mkt cap ! $2.782M
Open High Low Value Volume
0.3¢ 0.3¢ 0.3¢ $190 75.96K

Buyers (Bids)

No. Vol. Price($)
9 6258466 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 15952546 18
View Market Depth
Last trade - 15.12pm 31/07/2025 (20 minute delay) ?
1AD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.